52 POSTER Preclinical development of PTC299: an orally bioavailable small molecule drug that selectively inhibits the production of VEGF protein, tumor growth, and microvessel density (original) (raw)
52 POSTER Preclinical development of PTC299: an orally bioavailable small molecule drug that selectively inhibits the production of VEGF protein, tumor growth, and microvessel density
European Journal of Cancer Supplements, 2006
T. Davis
N. Tamilarasu
H. Qi
James Sheedy hasn't uploaded this paper.
Let James know you want this paper to be uploaded.
Ask for this paper to be uploaded.